Showing results (11-20 of 67) with videos related to
Sort By:
Pageof 7
Arthritis & Rheumatology (Hoboken, N.J.)|October 4, 2018
Rheumatic Syndromes Associated With Immune Checkpoint Inhibitors: A Single-Center Cohort of Sixty-One PatientsMichael D Richter, Cynthia Crowson, Lisa A Kottschade, et al.ACS Pharmacology & Translational Science|February 20, 2025
Performance Comparison of Liquid Chromatography and Paper Spray Ionization with Mass Spectrometry for Measuring Kinase Inhibitors in Human PlasmaRichard G Lahr, Makenzie Meyer, Leah Nelson, et al.Mayo Clinic Proceedings|October 6, 2012
Melanoma brain metastases and vemurafenib: need for further investigationNicole M Rochet, Roxana S Dronca, Lisa A Kottschade, et al.Melanoma Research|November 9, 2016
Effect of the lymphocyte-to-monocyte ratio on the clinical outcome of chemotherapy administration in advanced melanoma patientsAlexey A Leontovich, Roxana S Dronca, Wendy K Nevala, et al.Oncology (Williston Park, N.Y.)|February 15, 2012
In-transit melanoma: an individualized approachTravis E Grotz, Aaron S Mansfield, Lisa A Kottschade, et al.Supportive Cancer Therapy|July 18, 2008
Pilot evaluation of aprepitant for the treatment of hot flashesAditya Bardia, Susan Thompson, Pamela J Atherton, et al.Journal of the Society for Integrative Oncology|September 1, 2007
Pilot evaluation of flaxseed for the management of hot flashesSandhya Pruthi, Susan L Thompson, Paul J Novotny, et al.Journal of Surgical Oncology|December 12, 2017
Neoadjuvant systemic therapy for regionally advanced melanomaJames W Jakub, Jennifer M Racz, Tina J Hieken, et al.Melanoma Research|February 6, 2016
The use of pembrolizumab for the treatment of metastatic uveal melanomaLisa A Kottschade, Robert R McWilliams, Svetomir N Markovic, et al.Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 19, 2018
Brachial Plexus Neuritis Associated With Anti-Programmed Cell Death-1 Antibodies: Report of 2 CasesReem M Alhammad, Roxanna S Dronca, Lisa A Kottschade, et al.Pageof 7